Canada - English - Health Canada

sanofi pasteur limited - pertussis toxoid; filamentous haemagglutinin; fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; polyribose ribitol phosphate polysaccharide (prp); tetanus protein - liquid - 20mcg; 20mcg; 5mcg; 3mcg; 15lf; 5lf; 10mcg; 20mcg - pertussis toxoid 20mcg; filamentous haemagglutinin 20mcg; fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; polyribose ribitol phosphate polysaccharide (prp) 10mcg; tetanus protein 20mcg - vaccines

Canada - English - Health Canada

sanofi pasteur limited - pertussis toxoid; filamentous haemagglutinin; fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; polyribose ribitol phosphate polysaccharide (prp); tetanus protein - liquid - 10mcg; 5mcg; 5mcg; 3mcg; 15lf; 5lf; 10mcg; 30mcg - pertussis toxoid 10mcg; filamentous haemagglutinin 5mcg; fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; polyribose ribitol phosphate polysaccharide (prp) 10mcg; tetanus protein 30mcg - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct778 - bordetella ivds - for the in vitro qualitative detection and discrimination of bordetella pertussis and bordetella parapertussis in nasopharyngeal swabs (nps) from human patients with signs and symptoms of bacterial respiratory tract infection. for use on the 3m integrated cycler instrument.

Australia - English - Department of Health (Therapeutic Goods Administration)

esl biosciences australia 2012 pty ltd - ct778 - bordetella ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to bordetella pertussis toxin

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

csl limited - bordetella bronchiseptica - immunotherapy - dog | bitch | castrate | puppy - bordetella spp. | kennel cough | bordetella bronchiseptica | infectious tracheobronchitis

Australia - English - Department of Health (Therapeutic Goods Administration)

abacus dx pty ltd - ct778 - bordetella ivds - to be used in testing to provide information about infection with or exposure to bordetella bacteria

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct778 - bordetella ivds - for the detection and quantitation of antibodies to bordetella pertussis and bordetella pertussis toxin in human clinical samples.

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - ct778 - bordetella ivds - qualitative in vitro diagnostic tests that provide information about infection or exposure to bordetella bacteria. these devices are intended for use in hospital, reference or state laboratory settings. these devices are not intended for point of care use.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct778 - bordetella ivds - for in vitro diagnostic use in testing clinical specimens to provide information about infection with, or exposure to, bordetella bacteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct778 - bordetella ivds - the panther fusion bordetella assay is a multiplex real-time pcr in vitro diagnostic test for the rapid and qualitative detection and differentiation of bordetella pertussis (bp) and bordetella parapertussis (bpp). this assay is intended to aid in the differential diagnosis of bordetella pertussis and bordetella parapertussis infections in humans.